This hub covers pediatric epilepsy in infants, kids, and teens, including diagnosis, syndromes, development, school plans, and safety. New studies translated into clear takeaways for parents.
Usually when two appropriate medications haven’t controlled seizures.
Many families benefit and it depends on seizure frequency, medications, and learning needs.
Often yes, with smart precautions. Ask your neurologist or epileptologist about your child’s specific risks.
Clusters, prolonged seizures, breathing trouble, new weakness, or major regression.
This report describes one child: a 12-year-old girl who presented at age 11 with daily absence seizures that did not respond to multiple antiseizure medicines.
This study examined how intellectual test scores changed over time in children and adolescents who had brain surgery for pharmacoresistant epilepsy.
This study looked at thalamic neuromodulation for children with drug-resistant epilepsy, meaning epilepsy that did not respond well to medicines.
This study looked at whether brain PET scan templates made for children, and matched to different ages, can help improve localization of the epileptogenic zone, the brain area where seizures start, in children with drug-resistant epilepsy.
This paper reviewed published studies on using perampanel alone (monotherapy) in children with epilepsy.
This paper was a systematic review of randomized controlled trials about what to do after the first antiseizure medication (ASM) does not control focal epilepsy.
This study looked at adding ethosuximide, a seizure medicine, to treatment for children with developmental and epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS).
This study followed 35 children and adolescents with epilepsy who started levetiracetam, a common seizure medicine.
This article discusses a proposed way to personalize dosing of perampanel, a seizure medicine used in drug-resistant epilepsy.